Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study

Autor: Xue-Qin Xiong, Xi Lai, Juan Liu, Min Guo, Xiao Liu, Nali Hou, Qian Cheng, Xiao-Hua Liang, Ting Cui, Tingyu Li, Jie Chen, Ting Yang, Shu Liu
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Microbiology (medical)
DNA
Bacterial

Male
medicine.medical_specialty
Non-Randomized Controlled Trials as Topic
Autism Spectrum Disorder
lcsh:QR1-502
Child Behavior
Pilot Projects
Gut microbiota
Gut flora
Microbiology
lcsh:Microbiology
03 medical and health sciences
Feces
0302 clinical medicine
Internal medicine
RNA
Ribosomal
16S

mental disorders
medicine
Humans
Single-Blind Method
RNA
Messenger

Vitamin A
Child
biology
Infant
Autism spectrum disorders
medicine.disease
biology.organism_classification
Institutional review board
ADP-ribosyl Cyclase 1
Gastrointestinal Microbiome
Clinical trial
030104 developmental biology
Autism spectrum disorder
Child
Preschool

Immunology
Dietary Supplements
Childhood Autism Rating Scale
Autism
Female
Dysbiosis
030217 neurology & neurosurgery
Biomarkers
Research Article
Follow-Up Studies
Zdroj: BMC Microbiology
BMC Microbiology, Vol 17, Iss 1, Pp 1-14 (2017)
ISSN: 1471-2180
Popis: Background Dysbiosis of gut microbiota are commonly reported in autism spectrum disorder (ASD) and may contribute to behavioral impairment. Vitamin A (VA) plays a role in regulation of gut microbiota. This study was performed to investigate the role of VA in the changes of gut microbiota and changes of autism functions in children with ASD. Results Sixty four, aged 1 to 8 years old children with ASD completed a 6-month follow-up study with VA intervention. High-performance liquid chromatography was used to assess plasma retinol levels. The Autism Behaviour Checklist (ABC), Childhood Autism Rating Scale (CARS) and Social Responsiveness Scale (SRS) were used to assess autism symptoms. CD38 and acid-related orphan receptor alpha (RORA) mRNA levels were used to assess autism-related biochemical indicators’ changes. Evaluations of plasma retinol, ABC, CARS, SRS, CD38 and RORA mRNA levels were performed before and after 6 months of intervention in the 64 children. Illumina MiSeq for 16S rRNA genes was used to compare the differences in gut microbiota before and after 6 months of treatment in the subset 20 of the 64 children. After 6 months of intervention, plasma retinol, CD38 and RORA mRNA levels significantly increased (all P 0.05) in the 64 children. Meanwhile, the proportion of Bacteroidetes/Bacteroidales significantly increased and the proportion of Bifidobacterium significantly decreased in the subgroup of 20 (all false discovery rate (FDR) q
Databáze: OpenAIRE